Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report

Core Viewpoint - Agenus Inc. is set to release its fourth quarter and year-end 2023 financial results on March 14, 2024, before market opening, followed by a conference call for discussion [1]. Group 1: Financial Results Announcement - The financial results will be released before the market opens on March 14, 2024 [1]. - A conference call and webcast will take place at 8:30 a.m. ET on the same day to discuss the results and provide a corporate update [1]. Group 2: Company Overview - Agenus is a leader in immuno-oncology, focusing on cancer and infectious diseases with a diverse pipeline of immunological agents [3]. - The company's mission is to enhance patient access to cancer immunotherapy through combination therapies, utilizing a wide range of antibody therapeutics, adoptive cell therapies, and adjuvants [3]. - Agenus is headquartered in Lexington, MA, and provides regular updates on its website and social media channels [3].